Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic β cells: to be or not to be!-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic β cells: to be or not to be!

Published:2021-07-24 Issue:5-6 Volume:13 Page:106-114
ISSN:1938-2014
Container-title:Islets
language:en
Short-container-title:Islets

Author:

El-Huneidi Waseem¹,Hamad Mawieh²³^ORCID,Taneera Jalal¹²^ORCID

Affiliation:

1. Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates (UAE)

2. Department of Basic sciences, Sharjah Institute for Medical Research, Sharjah, University of Sharjah, United Arab Emirates (UAE)

3. Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah UAE

Funder

University of Sharjah

Publisher

Informa UK Limited

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/19382014.2021.1954458

Reference55 articles.

1. Real estimates of mortality following COVID-19 infection

2. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

4. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

5. U1 snRNP regulates cancer cell migration and invasion in vitro

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2;Metabolism;2024-07

2. COVID-19 and Diabetes: An Epidemiologic Overview;Pediatric Annals;2024-07

3. In Silico Antiviral Drug Repurposing Against COVID‐19 Infection: Targeting the Main Protease and Human ACE2 Receptor;ChemistrySelect;2023-12-19

4. Mesenchymal Stem Cells in the Treatment of COVID-19;International Journal of Molecular Sciences;2023-09-30

5. COVID-19 and diabetes;Probacja;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3